Grant: CIHR Fellowship
McGill University
$135,000.00
Gestational Diabetes: Reprogramming the Genome, a Potential Risk Factor for Adult Disease?
EF 2009-10
Résumé
Gestational diabetes frequently occurs during pregnancy. Numerous epidemiological human studies and animal studies have shown that an altered intrauterine environment, as is the case with gestational diabetes, impacts development leading to the onset of disease later in life. Specifically, there is an increased risk of developing obesity, type 2 diabetes and cardiovascular disease. Given the prevalence of gestational diabetes and the emerging pandemic of obesity and type 2 diabetes, it is imperative that we determine the underlying mechanism(s) involved. Strong evidence in literature now suggests that epigenetic modification of genes underlies disease. More recently, early life exposure has been shown to modify the epigenome of offspring, impacting adult health. I wish to undertake new studies aimed at elucidating the mechanisms involved in adverse neonatal outcome and late onset adult disease that result from an altered intrauterine environment. Further, I plan to identify at risk human populations. I now hypothesize that an altered metabolic intrauterine environment permanently changes fetal gene expression leading to adverse neonate outcome and disease in adulthood. Utilizing a combination of state-of-the-art molecular techniques and bioinformatics on mouse tissues (placenta, heart, pancreas and liver) and T-cells, in addition to biological data (i.e. glucose tolerance test) I plan to test my hypothesis. The results from this study will provide a better understanding of how an adverse intrauterine environment can lead to early life pathologies and late onset metabolic disease. Further, establishing correlations between specific epigenetic changes observed and outcome, will permit us to identify vulnerable human populations and subject them to preventative interventions. This intervention will hopefully reduce the rate of metabolic disease development and may also potentially minimize the risk of transmission of metabolic disease to future generations.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
203375
Name
Petropoulos Sophie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Gestational Diabetes: Reprogramming the Genome, a Potential Risk Factor for Adult Disease?
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bi-Sulfite Pyrosequencing; Cardiovascular Disease; Dna Methylation; Epigenetics; Gestational Diabetes; Neonatal Outcome; Obesity; Programming; Type Ii Diabetes; Whole Genome Arrays
Abstract
Gestational diabetes frequently occurs during pregnancy. Numerous epidemiological human studies and animal studies have shown that an altered intrauterine environment, as is the case with gestational diabetes, impacts development leading to the onset of disease later in life. Specifically, there is an increased risk of developing obesity, type 2 diabetes and cardiovascular disease. Given the prevalence of gestational diabetes and the emerging pandemic of obesity and type 2 diabetes, it is imperative that we determine the underlying mechanism(s) involved. Strong evidence in literature now suggests that epigenetic modification of genes underlies disease. More recently, early life exposure has been shown to modify the epigenome of offspring, impacting adult health. I wish to undertake new studies aimed at elucidating the mechanisms involved in adverse neonatal outcome and late onset adult disease that result from an altered intrauterine environment. Further, I plan to identify at risk human populations. I now hypothesize that an altered metabolic intrauterine environment permanently changes fetal gene expression leading to adverse neonate outcome and disease in adulthood. Utilizing a combination of state-of-the-art molecular techniques and bioinformatics on mouse tissues (placenta, heart, pancreas and liver) and T-cells, in addition to biological data (i.e. glucose tolerance test) I plan to test my hypothesis. The results from this study will provide a better understanding of how an adverse intrauterine environment can lead to early life pathologies and late onset metabolic disease. Further, establishing correlations between specific epigenetic changes observed and outcome, will permit us to identify vulnerable human populations and subject them to preventative interventions. This intervention will hopefully reduce the rate of metabolic disease development and may also potentially minimize the risk of transmission of metabolic disease to future generations.
Competitiondate
201002
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Petropoulos, Sophie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~